Alaunos Therapeutics effects 1-for-10 reverse stock split effective July 17, 2024

Alaunos Therapeutics, Inc.

Reverse split effective July 17, 2024 at 5:00 PM ET; every 10 pre-split shares become 1 post-split share.
Stockholders approved reverse split at June 6, 2024 annual meeting; board set 1-for-10 ratio on June 26, 2024.
Ticker TCRT unchanged; new CUSIP 98973P309; trading on split-adjusted basis from July 18, 2024.
Equiniti Trust Company appointed as exchange agent to handle shareholder share exchange.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.